Michael D Bookman's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 110,000 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 110,000 | 110,000 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 143,000 | 143,000 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 143,000 | 0 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 101,116 | 0 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 101,116 | 101,116 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 93,000 | 93,000 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 93,000 | 0 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,300 | 47,300 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2024 | 47,300 | 0 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 15 Mar 2024 | 1,448 | 3,850 | - | 1.6 | 2,346 | Class A Common Stock |
Immuneering Corp - Ordinar... | Bookman Michael D. | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 93,000 | 93,000 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 143,000 | 143,000 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | GENERAL COUNSEL AND SECRETARY | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 17 May 2022 | 1,000 | 2,402 | - | 4.9 | 4,880 | Class A Common Stock |
Immuneering Corp - Ordinar... | Michael D. Bookman | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 47,300 | 47,300 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Michael D. Bookman | General Counsel and Secretary | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 1,402 | 1,402 | - | 15 | 21,030 | Class A Common Stock |
Immuneering Corp - Ordinar... | Michael D. Bookman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 101,116 | 101,116 | - | - | Stock Option | |
Frequency Therapeutics Inc | Michael D. Bookman | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 30,000 | 30,000 | - | - | Restricted Stock Unit |